University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Insulin glargene 300 units/ml (Toujeo®)

Specialist initiation. For patients who require more than 80 units of insulin glargine per day and who are troubled by nocturnal hypos. Transfer to Primary Care should not happen until specialists can demonstrate reduction in nocturnal hypos (e.g. after 3–4 months). RICaD.

Status: Green Insulin glargine (lantus®)

Extremely high relative cost. Prescribe by brand name.

Status: Green Insulin glargine 100 units/ml (Abasalgar®)

Prescribe by brand name. First line for new patients initiated on insulin glargine 100 units/ml.

Status: Green Insulin glulisine (Apidra)

Prescribe by brand name

Status: Green Insulin humalog® mix 25

Prescribe by brand name

Status: Green Insulin humalog® mix 50

Prescribe by brand name

Status: Green Insulin humulin I® injection

Prescribe by brand name

Status: Green Insulin humulin S® injection

Prescribe by brand name

Status: Green Insulin humulin® M3 injection

Prescribe by brand name

Status: Green Insulin hypurin® bovine isophane injection

For existing patients only

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top